Elsevier Launches Malaria Nexus, Global Malaria Resource

OXFORD, England, August 11, 2010 /PRNewswire-FirstCall/ --

- New Online Knowledge Hub Aims to Become Leading Forum for Malaria Researchers, Editors and Opinion Leaders

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource, http://www.malarianexus.com.

Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet(R), The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.

"The aim of Malaria Nexus is to be a comprehensive resource and hub of knowledge for malaria researchers worldwide" said Dale Seaton, Executive Publisher for Parasitology, at Elsevier. "As well as making our latest malaria publications free to download, we want to go beyond the article, and become a leading forum for discussion between researchers, editors and opinion leaders."

The site features interviews with key authors, who can expand on their highlighted published work, as well as editors of some of Elsevier's most prestigious journal titles. Active participation and feedback from interested parties is encouraged. Currently featuring article feeds from 13 journals, the site will include additional relevant journals over the coming months.

John Beier, Editor of the participating journal Acta Tropica, said, "From remote settings in malaria endemic areas to sophisticated laboratories, malaria researchers from around the world will certainly benefit from using Malaria Nexus by reading timely highlights of first class publications, learning the views of leading malaria experts, and expressing their important opinions in this new forum for exchange of information."

For more information visit the site http://www.malarianexus.com and register for updates.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Matthew Smaldon
    Group Marketing Communications Manager - Elsevier
    +44(0)1865-843644
    [email protected]

SOURCE Elsevier